Concepedia

Thomas–Matthias Scherzer

TS

Statistics

Publications

13

Citations

1.2K

H-Index

13

Active since

2008

Affiliations

Medical University of Vienna(Current)

Medical University of Graz

Krankenhaus Oberndorf

Krankenhaus der Elisabethinen

Wilhelminen Hospital

Thomas–Matthias Scherzer is an author at Medical University of Vienna specializing in viral hepatitis, antiviral therapy, and ribavirin therapy.

Publications per year

2008–2022

13

Publications

13

Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response

Péter Ferenci, Hermann Laferl, Thomas–Matthias Scherzer et al. · Gastroenterology · 2008 · 252 citations · Full text

, , +16

Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy

Péter Ferenci, Thomas–Matthias Scherzer, Heidrun Kerschner et al. · Gastroenterology · 2008 · 242 citations

, , +14

Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease

Katharina Staufer, Ursula Huber-Schönauer, Georg Strebinger et al. · Journal of Hepatology · 2022 · 179 citations · Full text

, , +17

Peginterferon Alfa-2a/Ribavirin for 48 or 72 Weeks in Hepatitis C Genotypes 1 and 4 Patients With Slow Virologic Response

Peter Ferenci, Hermann Laferl, Thomas–Matthias Scherzer et al. · Gastroenterology · 2009 · 118 citations

, , +16

Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin

Thomas–Matthias Scherzer, Harald Hofer, A.F. Staettermayer et al. · Journal of Hepatology · 2010 · 74 citations

, , +16

1–5 of 13